PATH Resources

Our online catalog indexes publications, presentations, and related resources for peers in our field.

1752 Resources
1752 Resources
1752 Resources
    Date
  1. This report uses modeling to explore the potential impact - measured in lives saved - of regulatory harmonisation on accelerating access to health products across countries in Africa.
    Published: December 2018
    Type: Resource Page
  2. Oxygen therapy paired with pulse oximetry is being used to treat hypoxemia and save lives in Uganda. This brief outlines political recommendations for scaling up its use.
    Published: December 2018
    Type: Resource Page
  3. People-centered primary health care (PHC) is the foundation of health systems that put people first, address diverse health needs, & leave no one behind. We must harness the power of communities and information to accelerate progress toward the vision of health for all.
    Published: December 2018
    Type: Resource Page
  4. This web page provides technical information, resources, and links relevant to microarray patch (also known as MAPs or microneedle patches) development of high priority vaccine and essential medicines. Includes multisectoral information for the community of microarray patch researchers, manufacturers, stakeholders, and technology developers.
    Published: November 2018
    Type: Resource Page
  5. Cryptosporidium is an intestinal protozoan parasite that is a major cause of diarrheal disease among young children in low-resource settings. Beyond diarrheal disease, cryptosporidiosis is associated with other chronic conditions, including growth faltering, environmental enteric dysfunction, and possibly impaired cognitive development. Current therapeutic options are limited, with only one drug, nitazoxanide, approved by the United States Food and Drug Administration. There is only one drug in clinical trials against Cryptosporidium: clofazimine, a repurposed leprosy drug developed more than three decades ago. There are no vaccines for Cryptosporidium approved or in clinical development. This poster summarizes key initiatives to develop new Cryptosporidium drugs, including an overview of PATH's portfolio.
    Published: November 2018
    Type: Resource Page
Load more